In May 2020, Elekta announced that it will further develop its focus on cancer care providers and their patients through its acquisition of Kaiku Health. A key element of the acquisition was that the Kaiku platform can be integrated with Elekta’s MOSAIQ® Oncology Information System. Kaiku Health is now available in the US as a...
In the spring of 2020 the world had to quickly adapt to the new situation of COVID-19 spreading across the globe and causing lockdowns. The situation for us at Kaiku, was no different. The development of our product naturally needed to continue just like before – or even at a faster phase, as it could...
Kaiku Health has taken its first steps to tackle the big issue related to the challenge of identifying which patients are likely to benefit from immune checkpoint inhibitor (ICI) therapies. The unfortunate fact is that not all eligible patients respond to these therapies at all, and for some of those who have a response, it...
Kaiku Health, together with Oulu University Hospital, will present research at the ESMO Immuno-Oncology Congress 2020, which takes place as a virtual conference this year. The research investigates the use of Machine Learning to predict the objective response rate in immune checkpoint inhibitor treated patients when patient-reported and clinical data data are used as input...
Kaiku has continued its work among building machine learning (ML) based prediction models for immunotherapy-related symptom development. A year ago results from the first study were presented in the ESMO IO congress 2019 where it was showcased that ML based modeling of ePRO data on ICI treated cancer patients is feasible in predicting the onset...